Celebrating 50 Years of Advancing Diabetes Care & Education

Hosted by Nancy Hanna and Dena Gottesman

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.

This special episode is a compilation of conversations from the Association of Diabetes Care & Education Specialists (ADCES) 2023 conference in Houston. Joining Nancy on day 2 of the conference were a few very special guests. Alissa Heizler-Mendoza, a registered dietitian and certified diabetes care and education specialist dropped by the studio to discuss her role of leading the advocacy and government affairs team at Insulet. She empowers us to elevate our voices to influence change and help more people living with diabetes access life-changing technology.

Sarah Yourman-Tota also stopped by to chat with Nancy about her work in pediatric endocrinology, and the positive impact technology can have for caregivers. Nancy was also joined by Jennifer Boyd, medical science liaison at Insulet. Jenn discusses some patient success stories from one year of Omnipod 5.

Time stamps

2:38 – Hear how Insulet is working with patient and professional groups within the diabetes community such as ADCES, JDRF, and the Children’s Congress
10:20 – Sarah Yourman-Tota discusses the impact Omnipod-5 has had on the children and their caregivers at her clinic
20:18 – Jennifer Boyd Reviews the real-world data after Omnipod 5’s first year

 

See more episodes
This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.